The Quarter That Would Like to Be Forgotten, Please

India’s Most Integrated Chemical Mess (Lovingly)

Allow us to introduce Epigral Limited — a company that makes caustic soda, CPVC resin, epichlorohydrin, chloromethanes, hydrogen peroxide, and now chlorotoluene derivatives from a single complex in Dahej, Gujarat. If you’re wondering what any of those words mean, welcome to the club. The point is: they’re all connected in a giant backward-forward integrated chemical web, and when one link snaps, the whole sweater unravels.

This quarter, the snapping link was PVC. PVC prices in India dropped sharply, which dragged CPVC realizations down with a 1–2 month lag. Epigral happened to be holding a large inventory of CPVC at higher raw material costs right as spot prices were heading south. The result? A margin compression so brutal that even management used the phrase “this kind of situation was never seen” in the concall. That’s not exactly the language of confident cost-plus manufacturing.

But here’s the thing — strip out the inventory noise, and the underlying business looks reasonable. Volumes are mostly flat. Utilization sits at 78%. The new chlorotoluene plant commissioned in March 2025 is already delivering truckload shipments (not just samples) to customers. Capacity expansion for CPVC and ECH is on track for H1 FY27. And management has been remarkably candid about what broke, why, and when it should recover. That’s worth something in a sector where opacity is the industry standard.

They Make Scary-Sounding Chemicals. All in One Place. On Purpose.

The Epigral business model is what happens when a chemical company decides “why import when we can make it ourselves” — and keeps saying that until they’ve built an entire integrated complex. Start with salt. Make chlorine and caustic soda (chlor-alkali). Use chlorine to make chloromethanes, CPVC resin, epichlorohydrin, and now chlorotoluene derivatives. Use hydrogen from the process to generate power. Use the caustic for industrial customers. It’s a beautiful, nerdy, capital-intensive loop.

The revenue mix as of H1 FY25 is roughly 56% Derivatives & Specialty and 44% Chlor-alkali — a massive shift from FY22 when Derivatives were only 25%. That’s the entire strategy in one data point: move up the value chain, improve margins, reduce commodity exposure. It’s working — except when PVC decides to have a breakdown, which is what happened this quarter.

Key customers include Astral Pipes, Supreme, Atul, SRF, IPCA, Divis, and Vedanta. Their CPVC resin is the raw material that Indian pipe manufacturers put into your water supply lines — so every time Astral sells a pipe, Epigral sold the resin inside it. The company holds the distinction of running India’s first epichlorohydrin plant and its largest CPVC resin capacity at 75 KTPA. Not bad for a company that most retail investors had never heard of until the stock halved.

Q3 FY26: The Numbers (Brace Yourself)